October 2023 in “Case Reports” A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.
December 1990 in “PubMed” Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.
22 citations
,
May 1999 in “International Journal of Dermatology” Hair loss from genetics and hormones can be treated with drugs or surgery.
December 2025 in “Journal of Pharmacy And Bioallied Sciences” Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.
February 2024 in “Dermatology Reports” Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.
July 2023 in “International journal of trichology” The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.
81 citations
,
August 2011 in “Journal of The American Academy of Dermatology” Latanoprost 0.1% may effectively treat hair loss.
7 citations
,
January 1981 in “Springer eBooks” The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.
2 citations
,
November 1998 in “Journal of The European Academy of Dermatology and Venereology” A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.
March 2026 in “Pakistan Armed Forces Medical Journal” Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.
Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.
June 2022 in “Genetic engineering & biotechnology news” A new hair loss treatment is being developed using reprogrammed stem cells to grow new hair follicles.
January 1992 in “Juntendo Medical Journal” Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.
November 2025 in “Anxiety Stress & Coping” Higher anxiety symptoms and social behavior affect stress levels in hair.
August 2024 in “Frontiers in Public Health” Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.
January 2026 in “Journal of Pharmacy & Bioresources” Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.
July 2026 in “JEADV Clinical Practice” The SAAD-41 is a valid tool for assessing distress in people with Alopecia Areata.
6 citations
,
June 2022 in “Frontiers in Psychiatry” Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.
1 citations
,
November 2025 in “Journal of Health Psychology” Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.
September 2024 in “European Journal of Clinical and Experimental Medicine” Patients with hematologic cancer had mild anxiety, low surgical knowledge, and the pandemic increased their anxiety.
8 citations
,
June 2023 in “British Journal of Dermatology” The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.
January 2026 in “International Journal of Clinical Practice” People with alopecia areata often have higher anxiety and depression levels.
5 citations
,
October 2018 in “Research in psychotherapy” The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.
June 2024 in “British Journal of Dermatology” DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.
June 2024 in “British Journal of Dermatology” Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.
August 2025 in “Libyan Medical Journal” People with vitiligo or alopecia areata have higher anxiety and depression than healthy people.
69 citations
,
April 2017 in “BMJ open” Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.
October 2025 in “Tạp chí Y Dược học Cần Thơ” Anxiety is common in hair loss patients, especially women.
1 citations
,
January 2022 in “International Journal of Health Sciences” Health workers in non-COVID wards had higher depression and anxiety rates.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.